The Gulf Chronic Total Occlusion Registry
JACC: Advances · 2026-09 · 5 (9) · 103015
DOI: 10.1016/j.jacadv.2026.103015 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC: Advances, 2026-09. Verfasst von Amin Daoulah und 50 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, King Faisal Specialist Hospital & Research Center, Jeddah, Kingdom of Saudi Arabia. Electronic address: aminda…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Chronic total occlusion (CTO) is associated with increased ischemic burden, heart failure, and mortality. Comparative clinical outcomes associated with medical therapy, percutaneous coronary intervention (PCI), and coronary artery bypass grafting (CABG) remain uncertain. OBJECTIVES: To compare clinical outcomes associated with medical therapy, PCI, and CABG in patients with CTO. METHODS: We analyzed 741 patients with angiographically confirmed CTO enrolled across 7 tertiary centers in 4 Gulf countries between 2021 and 2023. Patients were managed with an initial strategy of medical therapy (n = 151), PCI (n = 441), or CABG (n = 149). The primary in-hospital endpoint was major adverse cardiovascular events. The long-term endpoint was major adverse cardiac and cerebrovascular events-free survival. RESULTS: Treatment allocation differed substantially by baseline clinical and angiographic risk. Medically managed patients had worse renal function, more severely reduced left ventricular ejection fraction, and more cardiogenic shock despite simpler CTO anatomy CABG patients had more extensive multivessel disease, whereas PCI patients had greater CTO lesion complexity. After adjustment, neither PCI nor CABG differed significantly from medical therapy for in-hospital major adverse cardiovascular events. At a median follow-up of 22 months, adjusted 36-month restricted mean survival time analyses showed no statistically significant difference in major adverse cardiac and cerebrovascular events-free survival between PCI, CABG, and medical therapy. Adjusted Canadian Cardiovascular Society class I at last follow-up was reached in 86.2% of medical therapy, 91.7% of PCI, and 98.0% of CABG patients; the adjusted difference vs medical therapy was significant for CABG (P < 0.001) but not for PCI P = 0.17). CONCLUSIONS: After adjustment, no treatment strategy demonstrated superiority for hard cardiovascular outcomes; revascularization, particularly CABG, was associated with a lower angina burden at follow-up.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, King Faisal Specialist Hospital & Research Center, Jeddah, Kingdom of Saudi Arabia. Electronic address: amindaoulah@yahoo.com.
- Department of Cardiology, International Medical Center, Jeddah, Kingdom of Saudi Arabia.
- Department of Cardiology, National Heart Center, Royal Hospital, Muscat, Sultanate of Oman.
- Department of Cardiovascular Medicine, Cleveland Clinic Abu Dhabi, UAE.
- Department of Cardiology, King Abdulaziz Specialist Hospital, Al Jawf, Kingdom of Saudi Arabia.
- Department of Medicine, University Medical City, Sultan Qaboos University Hospital Muscat, Sultanate of Oman.
Zitieren
APA
Daoulah, A., Kahin, M. A., Panduranga, P., Almahmeed, W., Abdulhabeeb, I. A. M., Alkindi, F., Lotfi, A., Seraj, S., Jamjoom, A., Arafat, A. A., Kanbr, O., Hussien, A. F., Alamro, B., Anthony, H., AlEidan, I. M., Livingston, G. S., Almarghany, A. A., Aslan, A. N., Elamin, S. M. S., …, & Elmahrouk, A. (2026). The Gulf Chronic Total Occlusion Registry. JACC: Advances, 5(9), 103015. https://doi.org/10.1016/j.jacadv.2026.103015
Vancouver
Daoulah A, Kahin MA, Panduranga P, Almahmeed W, Abdulhabeeb IAM, Alkindi F, et al. The Gulf Chronic Total Occlusion Registry. JACC: Advances. 2026;5(9):103015. doi:10.1016/j.jacadv.2026.103015
BibTeX
@article{Daoulah2026,
author = {Daoulah, Amin and Kahin, Mokhtar Abdirahman and Panduranga, Prashanth and Almahmeed, Wael and Abdulhabeeb, Ibrahim A M and Alkindi, Fahad and Lotfi, Amir and Seraj, Shaber and Jamjoom, Ahmed and Arafat, Amr A and Kanbr, Omar and Hussien, Adnan Fathey and Alamro, Bandar and Anthony, Harvey and AlEidan, Ibrahim Mohammed and Livingston, Gladsy Selva and Almarghany, Alsayed Ali and Aslan, Abdullah Nabi and Elamin, Sharafeldin M S and Al Mashari, Suhaib and Shantouf, Ronney and Noor, Taha H and Alryami, Adil and Alosaimi, Hind and Khan, Muhammad Asif and Dahdouh, Ziad and Balghith, Mohammed and Yousif, Nooraldaem and Noor, Husam A and Sadiq, Ather and Al Ismaili, Abdullah and Al Azzoni, Ashraf and Tammam, Khalid and Jamal, Syed and Khan, Hassan and Almubarak, Muhannad and Alanati, Hani Sulieman and Elmahrouk, Youssef and Chachar, Tarique Shahzad and Abohasan, Abdulwali and Jouda, Ahmed A and AlGhamdi, Abdulaziz and Al Maashani, Said and Ismail, Montaser Y and Arabi, Abdulrahman and Alquaid, Abdullah and Alshehri, Mohammed and Ross, Ethan M and Iqbal, Muhammad Nouman and Alsaadi, Rawan and Elmahrouk, Ahmed},
title = {The Gulf Chronic Total Occlusion Registry},
journal = {JACC: Advances},
year = {2026},
volume = {5},
number = {9},
pages = {103015},
doi = {10.1016/j.jacadv.2026.103015}
}
EUVIMED